← All trials
NCT02382263
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2013
- Primary completion
- Apr 1, 2016
- Completion date
- Apr 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 224
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- PH Research, S.L.Lead sponsor
- University of ValenciaOverall official - principal investigator
- Universitario de Santiago, SpainOverall official - principal investigator
- COMPLEJO HOSPITALARIO REGIONAL VIRGEN DE LAS NIEVESOverall official - principal investigator
- University of ZaragozaOverall official - principal investigator
- OsakidetzaOverall official - principal investigator
- Hospital Universitario Madrid SanchinarroStudy chair
- Clinica Universidad de NavarraOverall official - principal investigator
- Universidad Complutense de MadridOverall official - principal investigator
- Universidad Autonoma de BarcelonaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.